Tag: BestinClass

Structure Therapeutics CEO Envisions ‘Best-in-Class’ Weight-Loss Drug Amid Soaring Success

Structure Therapeutics (GPCR) said Monday patients who took a high dose of its GLP-1-targeted obesity treatment lost up to 15.3% more body weight than placebo recipients. Structure Therapeutics stock rose sharply in early trades. The results support plans to begin a Phase 3 study in mid-2026, Structure said in a news release. Chief Executive Raymond…

December 8, 2025

► Necessary Cookies Standard

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

None

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

None

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

None

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

None

Structure Therapeutics CEO Envisions ‘Best-in-Class’ Weight-Loss Drug Amid Soaring Success